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Enhancement of Chromosomal Damage by
Arsenic: Implications for Mechanism
by Janice W. Yager' and John K. Wiencke2
Arsenic is a naturally occurring metalloid that has been associated with increased incidence of human
cancerincertain highlyexposedpopulations.Arsenicisreleasedtotheenvironmentbynatural means suchas
solubilization fromgeologicformationsintowatersupplies.Itisalsoreleasedtooccupationalandcommunity
environmentsbysuchactivities asnonferrousoresmeltingandcombustionoffuelscontainingarsenic.Several
lines of evidence indicate that arsenic acts indirectly with other agents to ultimately enhance specific
genotoxic effects that may lead to carcinogenesis. Work described here indicates that arsenite specifically
potentiates chromosomal aberrations induced by aDNAcrosslinking agent, 1,3-butadiene diepoxide,but does
noteffecttheinductionofsisterchromatidexchangesunderthesametreatmentconditions. Itisproposedthat
the specific co-clastogenic effects ofarsenite seen here may be mediated by its interference with DNArepair
activities. Further understanding of the mechanism by which arsenic interacts with other environmental
agents will result in more accurate estimates ofrisk from exposure to arsenic.
Background
Arsenic is naturally occurring in various geological
formations andisreleased totheenvironmentbysolubiliz-
ationintogroundwater supplies (1). Release canalso occur
into community and occupational environments by such
activities as nonferrous ore smelting and production of
electric power by burning coal containing arsenic. When
such coal is combusted, minute quantities of arsenic are
emitted to the atmosphere depending on the arsenic con-
tent of the fuel. Arsenic content in U.S. bituminous coal
may vary from about 0.02 p,g/g up to 360 ,ug/g (2). Health
risk estimates for current coal-fired utility arsenic emis-
sionlevels have been derived usingtheinhalation unitrisk
estimates developed by the U.S. Enviromental Protection
Agency (EPA) (3). "Maximum individual lifetime" risk for
cancerfromarsenic from amodeled coal-fired powerplant
is estimated by EPA to be 1 x 10 -5.
Arsenic exists principally in two valence states: As3+
(arsenite) or As5+ (arsenate). Arsenite is considerably
more acutelytoxic than is arsenate, butthe relationship of
valence statetothepotentialinductionofcarcinogenesisis
unknown. Arsenic also existsin organic forms and is often
found in relatively high amounts in this form in fish as
arsenobetaine.
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Arsenicisawell-knowntoxinandisconsidered ahuman
carcinogen based on epidemiological evidence (4,5). Stud-
ies ofoccupational exposure to high air concentrations of
arsenicin coppersmelters (6-11) andcommunityexposure
to significant arsenic levels in drinking water (12) have
indicatedanincreasedriskoflungandskincancer,respec-
tively. Follow-up studies ofexposure to arsenic via drink-
ingwater in Taiwan have implied thatincreases in cancer
at other internal sites such as bladder and kidney may
have occurred as well (13-15). Populations studied in both
occupationalandcommunitysettingsweresimultaneously
exposed to complex mixtures of other compounds and
traceelements;thereisalsosomeevidencethatnutritional
and lifestyle factors such as smokingmayhaveinteracted
with arsenic to produce a synergistic response (16,17).
In animal studies, arsenical compounds alone have not
yielded a directly tumorigenic response (5). However, a
mixture ofarsenic trioxide, sulfuric acid, and particulates
did induce pulmonary carcinomas in hamsters when
administered by intratracheal instillation (18). Results of
animal studies provide support for the rationale that
arsenic acts in concert with other agents to alter or
enhance biological effects potentially including steps in
progression to carcinogenesis (19).
A number ofhypotheses have been described concern-
ing the possible mechanism ofaction ofarsenic in cancer.
Unlike most initiating chemicals, arsenic is inactive or
extremelyweakinitsabilityto directlyinduce genemuta-
tions; however, it does cause gene amplification and may
actasatumorpromoter(20,21). Ithasbeensuggestedthat
arsenicalcompoundsmayinteractantagonisticallyorsyn-YAGER AND WIENCKE
ergisticallywithothergenotoxicexposuresinhumans(22).
Epidemiological studies haveindicated asynergistic inter-
actionbetween arsenic exposure and cigarette smokingin
smelterworkers intheinduction oflungcancer(17,23) and
in the production of chromosomal aberrations in smelter
workers (24). Arsenite has been shown to enhance the
mutagenicityofUVtreatmentinbacterialcells(25)andto
inhibit DNA ligase activity in mammalian cells (26). The
induction of chromosomal aberrations in human cells by
DNA crosslinking agents combined with U light was
observed to be synergistically enhanced by arsenite (27-
29).
Tofurtherexplorethepossiblepotentiation ofgenotoxic
damage by arsenite, experiments were undertaken to
examine effects of arsenite exposure on the induction of
chromosomal aberrations and sister chromatid exchanges
by the DNA crosslinking agent 1,3-butadiene diepoxide
[DEB (30)].
Specificity of Arsenite in Enhancing
Chromosomal Effects
Methods
Peripheral lymphocytes from three subjects were
culturedin RPMI1640tissueculturemediumwith supple-
ments. Subject 1 was DEB-sensitive to sister chromatid
exchange (SCE) induction, whereas subjects 2 and 3were
resistantto suchinductionaspreviously described (31,32).
At24hrofculture, lymphocytes weretreatedwith0.5,1.0,
1.5, and 2.0 ,uM sodium arsenite or 6 ,uM DEB. In athird
seriesofexperiments, DEBandarsenitewerecombinedto
treatcultured cells. Inthisprotocol, DEBwas addedfirst,
followedimmediatelybyarsenite. Immediatelyaftertreat-
ment, 50 ,uM bromodeoxyuridine was added. Cells were
cultured for 72 hr at37.50C andtreatedwith colcemid 2 hr
before harvest. Standard chromosome preparations were
differentially stained using a modification of the
fluroescence-plus-Giemsa technique (33). For each sub-
ject, 100 first-division cells were scored per treatment for
aberration frequencies. Aberrations scored were chromo-
some-type aberrations and chromatid and isochromatid
deletions and chromatid exchanges. To estimate SCE fre-
quencies, 30 second-division cells were scored per point;
replication indexes were determined. Linear regression
wasappliedtoascertaintrendsinaberrationrates orSCE
frequencies. Pairwise differences between observed and
expected frequencies of chromosomal aberrations were
assessed by the chi-square test; the student's t-test was
used to test for differences in mean SCE frequencies.
Bonferroni's method to correct for multiple comparisons
was used to adjust the a level for significance (p < 0.05).
Results and Discussion
The yields oftotal chromosomal aberrations in lympho-
cytes exposed to both arsenite and DEB together were
markedly increased above the levels expected ifeffects of
the two agents had been simply additive (Fig. 1). For the
DEB-sensitive subject (Fig. la), more than 300 chromo-
some aberrations were induced per 100 cells with the
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FIGURE 1. The effects of combined treatment with sodium arsenite
(NaAsO2) and 6 pM1,3-butadiene diepoxide (DEB) toproduceenhanced
yields of total chromosomal aberrations. (A) Results from subject 1,
whose lymphocytes were relatively sensitive to induction ofsister chro-
matid exchanges (SCEs) by DEB. (B) Results from subject 2, whose
lymphocytes were relatively resistant to DEB-induced SCEs. (*)
Observed frequency significantly different from expected (p < 0.05; x2
test); (**) observed frequencysignificantly differentfromexpected (p <
0.001; X2 test).
combinedtreatmentat2 ,uMsodiumarsenite-anapprox-
imately 10-fold increase above expected.
As seenin Figure lb,results ofthe combinedtreatment
for subject2, whose cells were relativelyresistant to SCE
inductionbyDEB,showedsimilarresults. Inthisinstance,
however, about a 5-fold increase in the number ofchromo-
some aberrations was observed relative to the number
expected. Cells from subject 3 showed similar results.
In contrast, as shown in Figure 2, the yields ofinduced
SCEs are additive for the combined DEB plus arsenite
treatments, thustheexpectedandobservedfrequenciesof
SCEs are not significantly different. There were no sub-
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FIGURE 2. The effect of combined treatment with sodium arsenite
(NaAsO2) and 6 ,uM 1,3-butadiene diepoxide on induction of sister
chromatid exchanges (SCEs) in subject 1. No significant differences
between expected and observed SCE frequencies were noted for any of
the three subjects. Allvalues havebeen corrected bysubtracting outthe
appropriate control (background) SCE frequency.
stantial differences amongthe three subjects with regard
to this response.
These results show that arsenite acts synergistically
withDEBintheinduction ofchromosomalaberrationsbut
does not affect the yield of DEB-induced SCEs. Inter-
estingly, neither the DEB-sensitive nor DEB-resistant
subjects showed a synergistic effect with arsenite in the
induction ofDEB-induced SCEs. In contrast, theinterac-
tionofarsenitewith DEBintheinduction ofchromosomal
aberrations wasfound tobe greatest inlymphocytes from
the subject sensitive to SCE induction by DEB.
Although it has been recognized that arsenite reacts
withproteinsulfhydrylgroups,ithasnowbeenshownthat
arsenite may be highly selective in reacting with only a
small number ofclosely spaced dithiol groups in proteins
(34,35). Suchdithiolgroups arerelativelycommon inDNA-
associated protein molecules including DNA repair pro-
teins (36). Specifically, the activityofDNAligase, a mam-
malian DNA repair protein, has been shown to be
inhibited by arsenite (26).
Conclusion
Arsenicisaubiquitous metalloid knowntobeassociated
at relatively high exposure concentrations with an
increasedriskforcertaincancers inhumans.Arsenicdoes
not appear to act directly as an initiator, but rather indi-
rectly by as yet unknown mechanism(s) to enhance the
effect of other genotoxic agents. Understanding of such
mechanisms has implications for the shape of the dose-
response curve. Recent studies, including the study sum-
marized here, provide further evidence for arsenite as a
co-clastogen. This study also suggests a specific interac-
tion of arsenite with the induction or repair of DNA
damage produced by DEB that leads to chromosomal
aberrations but not to SCEs. Further studies are neces-
sary to identify DNA repair proteins containing dithiol
groups sensitive to low concentrations of arsenic. This
work and other studies previously discussed support the
proposal that arsenic exposure in combination with other
DNAdamaging agents leads to a specific enhancement of
effects related to genotoxicity that may be important in
development ofcancer.
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